Protection Against COVID-19 and Infections With SARS CoV 2
Showing 1 - 25 of >10,000
COVID-19, Protection Against COVID-19 and Infections With SARS-CoV- 2, COVID-19 Immunisation Trial in Italy (COVID-eVax,
Active, not recruiting
- COVID-19
- +2 more
- COVID-eVax
- Cliniporator® and EPSGun
-
Monza, Italy
- +3 more
Dec 20, 2021
COVID-19, Vaccine-Preventable Diseases, SARS CoV 2 Infection Trial (Novavax COVID-19 vaccine (2023-2024 formula XBB containing),
Not yet recruiting
- COVID-19
- +4 more
- Novavax COVID-19 vaccine (2023-2024 formula XBB containing)
- Pfizer COVID-19 mRNA vaccine (2023-2024 formula XBB containing)
- (no location specified)
Sep 29, 2023
Coronavirus, SARS-CoV-2 Infection, COVID-19 Trial in Lausanne (LD Vehicle-GNP, LD PepGNP-SARSCoV2, HD Vehicle-GNP)
Completed
- Coronavirus
- +2 more
- LD Vehicle-GNP
- +3 more
-
Lausanne, Vaud, SwitzerlandCenter for Primary Care and Public Health (Unisante)
Nov 28, 2022
Coronavirus Trial in Oxford (SARS-CoV-2 virus)
Recruiting
- Coronavirus
- SARS-CoV-2 virus
-
Oxford, Oxon, United Kingdom
- +2 more
Jan 5, 2023
COVID-19, Respiratory Tract Infections Trial in Oslo (Wearing glasses (any type))
Recruiting
- COVID-19
- Respiratory Tract Infections
- Wearing glasses (any type)
-
Oslo, NorwayNorwegian Institute of Public Health
Apr 19, 2022
Immunogenicity, Safety Trial (Phase II:SWIM816;SARS-Cov-2;, Phase II:SW-BIC-213;SARS-Cov-2;, PhaseIII:SWIM816;SARS-Cov-2;)
Not yet recruiting
- Immunogenicity
- Safety
- Phase II:SWIM816;SARS-Cov-2;
- +3 more
- (no location specified)
Jun 18, 2023
CORONAVIRUS INFECTIONS Trial (anti-SARS-Cov-2 vaccination)
Not yet recruiting
- CORONAVIRUS INFECTIONS
- anti-SARS-Cov-2 vaccination
- (no location specified)
Dec 15, 2022
Certain Disorders Involving the Immune Mechanism Trial in Tours (Sampling, PCR (polymerase chain reaction) SARS-CoV-2)
Not yet recruiting
- Certain Disorders Involving the Immune Mechanism
- Sampling
- PCR (polymerase chain reaction) SARS-CoV-2
-
Tours, FranceCHRU de Tours
Nov 17, 2023
Against SARS-CoV-2 (COVID-19)in Dazhu County in 2023
Recruiting
- COVID-19
-
Dazhou, Sichuan, ChinaDazhu County Center for Disease Control and Prevention
Mar 7, 2023
COVID-19, SARS-CoV-2 Trial in Seoul (QTP104 1ug, QTP104 5ug, QTP104 25ug)
Active, not recruiting
- COVID-19
- SARS-CoV-2
- QTP104 1ug
- +2 more
-
Seoul, Korea, Republic of
- +1 more
May 24, 2023
Zinc Deficiency, Sars-CoV-2 Infection Trial in Barcelona (Zinc Acetate)
Completed
- Zinc Deficiency
- Sars-CoV-2 Infection
- Zinc Acetate
-
Barcelona, SpainHospital del Mar
Mar 18, 2023
SARS-CoV-2 RBD Antibody in My Duc Hospital Healthcare Workers
Completed
- Covid19
- Vaccine Reaction
- SARS-CoV-2 IgG II Quant
-
Ho Chi Minh City, Tan Binh, VietnamHOPE Research Center, My Duc Hospital
Aug 20, 2022
COVID-19 Vaccine Trial in Ciudad Autónoma de Buenos Aires (ARVAC-CG vaccine (recombinant protein vaccine against SARS-CoV-2))
Active, not recruiting
- COVID-19 Vaccine
- ARVAC-CG vaccine (recombinant protein vaccine against SARS-CoV-2)
-
Ciudad Autónoma de Buenos Aires, ArgentinaUnidad de Investigación Clínica Farmacocinética FP Clinical Phar
Dec 21, 2022
SARS-CoV-2 Infection, COVID-19 Trial in Sumida-ku, Fukuoka (BNT162b2, Placebo)
Completed
- SARS-CoV-2 Infection
- COVID-19
- BNT162b2
- Placebo
-
Sumida-ku, Tokyo, Japan
- +1 more
Jan 13, 2023
COVID-19, SARS-CoV 2, Severe Acute Respiratory Syndrome Coronavirus 2 Trial in San Francisco (Oral-B Mouth Sore mouthwash, Crest
Recruiting
- COVID-19
- +5 more
- Oral-B Mouth Sore mouthwash
- +4 more
-
San Francisco, CaliforniaUniversity Of California, San Francisco
May 17, 2022
COVID-19 Trial in Gaborone (AZD 1222)
Completed
- COVID-19
- AZD 1222
-
Gaborone, BotswanaBotswana Harvard Health Partnership
Feb 6, 2023
COVID-19, COVID-19 Pneumonia, COVID-19 Respiratory Infection Trial in Caracas (Carvacrol, Control group)
Completed
- COVID-19
- +4 more
- Carvacrol
- Control group
-
Caracas, Miranda, VenezuelaHospital Dr. Leopoldo Manrique Terrero - Periférico de Coche.
Jul 5, 2022
COVID-19 Infection, Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Seattle (Questionnaire Administration,
Suspended
- COVID-19 Infection
- +2 more
- Questionnaire Administration
- Sotrovimab
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 24, 2023
Cancer Trial in Anderlecht (Spikevax, Comirnaty)
Recruiting
- Cancer
- Spikevax
- Comirnaty
-
Anderlecht, Belgium
- +1 more
Aug 30, 2022
Covid19 Trial in Lenexa, Raleigh (Investigational vaccine against SARS-CoV-2 [MV-014-212] Dosage 1, Single Dose, Intranasal
Recruiting
- Covid19
- Investigational vaccine against SARS-CoV-2 [MV-014-212] Dosage 1, Single Dose, Intranasal Drops
- +4 more
-
Lenexa, Kansas
- +1 more
Aug 1, 2022
COVID-19 Vaccine Trial in Argentina (Gamma Variant RBD-based ARVAC-CG vaccine, Omicron Variant RBD-based ARVAC-CG vaccine,
Recruiting
- COVID-19 Vaccine
- Gamma Variant RBD-based ARVAC-CG vaccine
- +3 more
-
Argentina, C.a.b.a., ArgentinaCentro de Educación Médica e Investigaciones Clínicas "Norberto
Feb 28, 2023
COVID-19 Respiratory Infection Trial in Sulaymaniyah (Vitamin-D)
Completed
- COVID-19 Respiratory Infection
- Vitamin-D
-
Sulaymaniyah, IraqHawal Lateef Fateh
May 10, 2023
SARS-CoV-2/COVID-19 Study of Next Generation Non-Invasive
Not yet recruiting
- COVID-19
- +5 more
- imPulse™ Una infrasound-to-ultrasound e-stethoscope
- (no location specified)
Mar 9, 2023
Against Sars-Cov2 Virus in Received EU-approved COVID-19
Completed
- SARS-CoV2 Infection
- Vaccine Reaction
- Approved vaccines against Sars-Cov2
-
Patras, GreeceUniversity Hospital of Patras
Jun 2, 2022